NCT06111235Phase 3Active not recruiting

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Study sponsor: CG Oncology, Inc. · CGON

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-11Estimated
Enrollment · participants367Actual
Source updated2026-07-01Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

Jun 2026

+ After

Nov 2026

Check registry source

· 1 field changed

Primary completion date changed

− Before

Jan 2028

+ After

Jun 2026

Check registry source